Search

Chicago-based telemedicine provider raises $6.5 million

CHICAGO-BASED TELEMEDICINE PROVIDER RAISES $6.5 MILLION

The First Stop Health funding round was led by Morningstar Chairman and Founder Joe Mansueto and Rich Gallun, the co-founder of employee...

Medici buys startup Chiron Health to further telemedicine goals

MEDICI BUYS STARTUP CHIRON HEALTH TO FURTHER TELEMEDICINE GOALS

The Chiron Health deal follows Medici's recent acquisition of another company called DocbookMD.

 
 
 
Bristol-Myers Squibb to acquire Celgene in $74B deal

BRISTOL-MYERS SQUIBB TO ACQUIRE CELGENE IN $74B DEAL

The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly...

BIOCHEMIST AND ENZYME ENGINEER - SD SYN BIOTECH - CARLSBAD, CA

About SD Syn Biotech:. Scientist, biochemistry, yeast, bacteria, biosensor, laboratory, biotech, biology, genetic, protein, enzyme,...

 
 
 
Administration stops NIH scientists from obtaining fetal tissue, possibly threatening HIV research

ADMINISTRATION STOPS NIH SCIENTISTS FROM OBTAINING FETAL TISSUE, POSSIBLY THREATENING HIV RESEARCH

Science magazine reported that the move put the brakes on a preclinical HIV study and follows the cancellation of a contract between...

Final agenda for INVEST 2019 published as MedCity invites speaker applications

FINAL AGENDA FOR INVEST 2019 PUBLISHED AS MEDCITY INVITES SPEAKER APPLICATIONS

The agenda for INVEST 2019 has been finalized as we gear up for our annual flagship conference in Chicago, April 23-24 and invite speakers...

 
 
 
Imfinzi looks flimsy in AstraZeneca's Phase III head and neck cancer study

IMFINZI LOOKS FLIMSY IN ASTRAZENECA'S PHASE III HEAD AND NECK CANCER STUDY

Results of the Phase III EAGLE study leave Merck's Keytruda and Bristol's Opdivo as the dominant players in the space of HNSCC after...

Home health company Mavencare expands to Boston

HOME HEALTH COMPANY MAVENCARE EXPANDS TO BOSTON

The organization, which leverages technology to provide care to seniors in their own homes, also serves the Toronto and New York City...

 
 
 
Carelinx launches home-care service for Medicare Advantage plans

CARELINX LAUNCHES HOME-CARE SERVICE FOR MEDICARE ADVANTAGE PLANS

CMS's expansion of the health related supplemental benefits that can be covered by Medicare Advantage has opened up a lucrative new...

FDA approval puts Loxo, Bayer's Vitrakvi on the rails to value-based care

FDA APPROVAL PUTS LOXO, BAYER'S VITRAKVI ON THE RAILS TO VALUE-BASED CARE

That the drug will only be given to patients shown through testing to harbor a genetic anomaly that increases the odds of a response...

 
 
 
FDA approves Celltrion, Teva's Rituxan biosimilar, but with a narrow label

FDA APPROVES CELLTRION, TEVA'S RITUXAN BIOSIMILAR, BUT WITH A NARROW LABEL

The agency approved Truxima for three lymphoma indications, whereas European regulators approved it last year for all the same indications...

Amazon's latest healthcare foray is a major step into health informatics

AMAZON'S LATEST HEALTHCARE FORAY IS A MAJOR STEP INTO HEALTH INFORMATICS

A new software service from the company called Amazon Comprehend Medical uses machine learning and natural language processing to extract...

 
 
 
UK's top drug regulator heads for the exit

UK'S TOP DRUG REGULATOR HEADS FOR THE EXIT

Ian Hudson, CEO of the MHRA, will step down in September 2019. He cited the country's withdrawal from the European Union as a key factor.

Report: Walgreens and Humana looking to take equity stakes in each other

REPORT: WALGREENS AND HUMANA LOOKING TO TAKE EQUITY STAKES IN EACH OTHER

The two companies are already working together on a pilot program putting senior-focused primary care centers in Walgreens stores located...

 
 
 
What health IT needs to look like in 2019 to be successful

WHAT HEALTH IT NEEDS TO LOOK LIKE IN 2019 TO BE SUCCESSFUL

It's not enough for health IT just to presents dashboards. To be successful in 2019, the data needs to tell a story and result in meaningful...

Report: Cancer clinical trials tech startup Driver shutters two months after launch

REPORT: CANCER CLINICAL TRIALS TECH STARTUP DRIVER SHUTTERS TWO MONTHS AFTER LAUNCH

The high cost to join the platform - which combined molecular pathology labs with a mobile app - played a role in its low sign-up numbers,...

 
 
 
Aetna forced to pay $25M after denying coverage to cancer patient

AETNA FORCED TO PAY $25M AFTER DENYING COVERAGE TO CANCER PATIENT

Jurors ordered the payment after ruling that Aetna failed to deal in good faith in determining whether or not to cover proton beam...

FDA commissioner highlights efforts to improve expanded access program

FDA COMMISSIONER HIGHLIGHTS EFFORTS TO IMPROVE EXPANDED ACCESS PROGRAM

The agency also launched in information website about Right to Try, which President Donald Trump signed into law in May.

 
 
 
Biopharma needs a new R&D, innovation model

BIOPHARMA NEEDS A NEW R&D, INNOVATION MODEL

Strategic partnerships are one way for biopharmaceutical companies to expand capabilities and offerings and proactively define their...

What barriers are preventing patients from getting mental health services?

WHAT BARRIERS ARE PREVENTING PATIENTS FROM GETTING MENTAL HEALTH SERVICES?

New research from AbleTo, a provider of tech-enabled behavioral health solutions, found cost and stigma remain two of the primary reasons...